Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (292)	8/4/2003 6:46:56 PM
From: Madharry	Read Replies (2) of 824

is it common for these pr releases to be so cryptic- it would have been nice for him to tell us the actual numbers. Am i interpreting this correctly that if A is the subclass of CABG without valve replacement and B is the subclass of CABG with valve replacement. that the endpoint was not achieved for A but it was achieved for A+B. is that how you understand it as well? Why do you think that would be the case? is it possible that the patients which only need CABG are alot healthier than the second group and therefore the mortality rate is very small to begin with? Also the formal announcement i guess will only be made tomorrow shortly before the market opens. I am suspicious that the institutions will know before that what is going on. and will be able to make much more informed decision than us poor relatives.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next